U.S. CEOs threaten to 'turn up the noise' over ObamaCare workplace wellness lawsuits


Calling recent lawsuits filed by the Obama administration's Equal Employment Opportunity Commission a "major issue," a group of U.S. chief executives representing more than 200 corporations are threatening to pull their support for ObamaCare, Reuters reports.
"We never did this before," said one person familiar with the issue. "But they could turn up the noise."
At the center of the argument is a "workplace wellness" provision, which allows companies to lower healthcare costs by rewarding workers who sign up for programs aimed at reducing smoking, obesity, and other issues that can increase healthcare costs. The provision also allows corporations to penalize employees who do not take part.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
But the EEOC has brought lawsuits against several companies arguing that the detailed health questionnaires and medical screenings that employees must fill out to participate in the wellness programs undermine the Americans with Disabilities Act. And, because not participating can cost employees as much as $4,000 in penalties, the EEOC argues that the programs are not actually voluntary. What is unclear is whether the White House — which created the healthcare reform law and included the wellness provision — is even able to stop the EEOC from challenging the programs.
"(Companies) don't understand why a plan in compliance with the ACA is the target of a lawsuit," Maria Ghazal, vice president of the Business Roundtable group, said.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Sarah Eberspacher is an associate editor at TheWeek.com. She has previously worked as a sports reporter at The Livingston County Daily Press & Argus and The Arizona Republic. She graduated from Northwestern University's Medill School of Journalism.
-
Road trip: New England’s maple syrup season
Feature New England is serving up maple syrup in delicious and unexpected ways
By The Week US Published
-
Music Reviews: Mdou Moctar, Panda Bear, and Tate McRae
Feature “Tears of Injustice,” “Sinister Grift,” and “So Close to What”
By The Week US Published
-
What's at stake in the Mahmoud Khalil deportation fight?
Talking Points Vague accusations and First Amendment concerns
By Joel Mathis, The Week US Published
-
RFK Jr. offers alternative remedies as measles spreads
Speed Read Health secretary Robert F. Kennedy Jr. makes unsupported claims about containing the spread as vaccine skepticism grows
By Peter Weber, The Week US Published
-
Texas outbreak brings 1st US measles death since 2015
Speed read The outbreak is concentrated in a 'close-knit, undervaccinated' Mennonite community in rural Gaines County
By Rafi Schwartz, The Week US Published
-
Mystery illness spreading in Congo rapidly kills dozens
Speed Read The World Health Organization said 53 people have died in an outbreak that originated in a village where three children ate a bat carcass
By Peter Weber, The Week US Published
-
Ozempic can curb alcohol cravings, study finds
Speed read Weight loss drugs like Ozempic and Wegovy may also be helpful in limiting alcohol consumption
By Peter Weber, The Week US Published
-
New form of H5N1 bird flu found in US dairy cows
Speed Read This new form of bird flu is different from the version that spread through herds in the last year
By Peter Weber, The Week US Published
-
Microplastics accumulating in human brains, study finds
Speed Read The amount of tiny plastic particles found in human brains increased dramatically from 2016 to 2024
By Peter Weber, The Week US Published
-
FDA approves painkiller said to thwart addiction
Speed Read Suzetrigine, being sold as Journavx, is the first new pharmaceutical pain treatment approved by the FDA in 20 years
By Rafi Schwartz, The Week US Published
-
Study finds possible alternative abortion pill
Speed Read An emergency contraception (morning-after) pill called Ella could be an alternative to mifepristone for abortions
By Peter Weber, The Week US Published